Management of Neurogenic Orthostatic Hypotension

被引:9
|
作者
Arbique, Debbie [1 ]
Cheek, Dennis [2 ,3 ]
Welliver, Mark [2 ,3 ]
Vongpatanasin, Wanpen [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Div Cardiol, Hypertens Sect, Dallas, TX 75390 USA
[2] Texas Christian Univ, Harris Coll Nursing & Hlth Sci, Ft Worth, TX 76129 USA
[3] Texas Christian Univ, Sch Nurse Anesthesia, Ft Worth, TX 76129 USA
关键词
Neurogenic orthostatic hypotension; physiology and pathophysiology with standing; supine hypertension; neurogenic; diagnostic tests; pharmacological and nonpharmacological; mortality; morbidity; BLOOD-PRESSURE; AUTONOMIC DYSFUNCTION; ATHEROSCLEROSIS RISK; WATER DRINKING; PATHOPHYSIOLOGY; HYPERTENSION; ADULTS; MIDODRINE; DIAGNOSIS; SYNCOPE;
D O I
10.1016/j.jamda.2013.10.014
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The burden of orthostatic hypotension (OH) on public health is a universally recognized enigmatic clinical condition that is associated with significant increases on morbidity and mortality rates, and can take a major toll on one's quality of life. Orthostatic hypotension is predictive of vascular deaths from acute myocardial infarction, strokes in the middle aged population, and increases mortality rates when associated with diabetes, hypertension, Parkinson's disease, and patients receiving renal dialysis. The consensus definition for OH is a fall in systolic blood pressure of at least 20 mm Hg and/or diastolic blood pressure of at least 10 mm Hg within 3 minutes of quiet standing. Because neurogenic OH is often accompanied by supine hypertension, the treatment program should aim toward minimizing OH and the potential fall injuries related to cerebral hypoperfusion without exacerbating nocturnal hypertension that may lead to excessive cardiovascular complications. (C) 2014 - American Medical Directors Association, Inc. All rights reserved.
引用
下载
收藏
页码:234 / 239
页数:6
相关论文
共 50 条
  • [1] Management of neurogenic orthostatic hypotension: an update
    Low, Phillip A.
    Singer, Wolfgang
    [J]. LANCET NEUROLOGY, 2008, 7 (05): : 451 - 458
  • [2] New Developments in the Management of Neurogenic Orthostatic Hypotension
    Italo Biaggioni
    [J]. Current Cardiology Reports, 2014, 16
  • [3] Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management
    Manuela Metzler
    Susanne Duerr
    Roberta Granata
    Florian Krismer
    David Robertson
    Gregor K. Wenning
    [J]. Journal of Neurology, 2013, 260 : 2212 - 2219
  • [4] New Developments in the Management of Neurogenic Orthostatic Hypotension
    Biaggioni, Italo
    [J]. CURRENT CARDIOLOGY REPORTS, 2014, 16 (11) : 1 - 8
  • [5] Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management
    Metzler, Manuela
    Duerr, Susanne
    Granata, Roberta
    Krismer, Florian
    Robertson, David
    Wenning, Gregor K.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2212 - 2219
  • [6] Neurogenic orthostatic hypotension
    Freeman, Roy
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06): : 615 - 624
  • [7] Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension
    Jacquie Baker
    Kurt Kimpinski
    [J]. CNS Drugs, 2017, 31 : 653 - 663
  • [8] Management of neurogenic orthostatic hypotension in the heart failure patient
    Dixon, Debra D.
    Muldowney, James A. S., III
    [J]. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2020, 227
  • [9] Management of Neurogenic Orthostatic Hypotension in Patients with Autonomic Failure
    Christoph Schroeder
    Jens Jordan
    Horacio Kaufmann
    [J]. Drugs, 2013, 73 : 1267 - 1279